Table 3 Differentially expressed proteins with % volume and related statistical parameters of treated MS (RRt), untreated MS (RRu) and healthy control (HC) subjects
From: The clinical potential of blood-proteomics in multiple sclerosis
Entry name | Average Vol% RRu (SD; range) | Average Vol% HC (SD; range) | Average Vol% RRt (SD; range) | RRu change with respect to HC (Vol% ratio; p) | RRu change with respect to RRt (Vol% ratio; p) | Levene’s test for equality of variance (RRu/HC) | Levene’s test for equality of variance (RRt/RRu) |
|---|---|---|---|---|---|---|---|
Rho GDI2 | 0.7340 (0.26; 0.60) | 1.9738 (0.28; 0.95) | // | Down 2.8; (p = 0.000) | // | n.s. | // |
Rab GDIβ (Rab2) | 0.2883 (0.04; 0.12) | 0.0976 (0.05; 0.19) | // | Down 2.9; (p = 0.000) | // | n.s. | // |
Cofilin 1 | 0.1946 (0.10; 0.24) | 0.9651 (0.48; 1.83) | // | Down 4.9; (p = 0.000) | // | p = 0.043 | // |
Cortactin | 0.3912 (0.04; 0.11) | // | 0.0546 (0.04; 0.13) | // | Up 7.1; (p = 0.000) | // | n.s. |
Fibrinogen β Chain Precursor | 0.1372 (0.02; 0.08) | // | 0.0039 (0.01; 0.03) | // | Up 35.1; (p = 0.000) | // | n.s. |